We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
-0.48%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$5.75B
AUM Growth
+$1.94B
(+51%)
Cap. Flow
+$2.28B
Cap. Flow
% of AUM
39.59%
Top 10 Holdings %
Top 10 Hldgs %
3.98%
Holding
4,587
New
1,332
Increased
1,451
Reduced
987
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$34.9M |
| 2 |
GE Aerospace
GE
|
+$20.6M |
| 3 |
Goldman Sachs
GS
|
+$18.9M |
| 4 |
Duke Energy
DUK
|
+$18.8M |
| 5 |
Boston Scientific
BSX
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$27.9M |
| 2 |
JPMorgan Chase
JPM
|
+$24M |
| 3 |
Kroger
KR
|
+$17.5M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.84% |
| 2 | Technology | 14.68% |
| 3 | Industrials | 13.97% |
| 4 | Healthcare | 11.52% |
| 5 | Consumer Discretionary | 11.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
InflaRx
IFRX
$256M
| $79.5K | ﹤0.01% |
88,908
-44,852
| -34% | -$42.4K |
|
3177
Travelzoo
TZOO
$103M
| $79.4K | ﹤0.01% |
+13,413
| New | +$81.5K |
|
|
WHWK
3178
Whitehawk Therapeutics
WHWK
$183M
| $79.3K | ﹤0.01% |
22,983
+7,279
| +46% | +$22.8K |
|
|
WKEY
3179
WISeKey
WKEY
$71.6M
| $78.5K | ﹤0.01% |
+12,788
| New | +$95.5K |
|
3180
Cumberland Pharmaceuticals
CPIX
$99M
| $78K | ﹤0.01% |
+24,006
| New | +$92.5K |
|
|
AUTL
3181
Autolus Therapeutics
AUTL
$386M
| $77.8K | ﹤0.01% |
56,405
-72,841
| -56% | -$111K |
|
3182
Nuvectis Pharma
NVCT
$609M
| $77.8K | ﹤0.01% |
+10,066
| New | +$86.2K |
|
|
WIMI
3183
WiMi Hologram Cloud
WIMI
$21.1M
| $77.8K | ﹤0.01% |
40,514
+9,945
| +33% | +$21.1K |
|
3184
Dominari Holdings
DOMH
$59.7M
| $77.4K | ﹤0.01% |
+23,805
| New | +$85.4K |
|
3185
Oramed Pharmaceuticals
ORMP
$165M
| $77.1K | ﹤0.01% |
22,688
-15,494
| -41% | -$52.6K |
|
|
MVO
3186
MV Oil Trust
MVO
$6.85M
| $76.9K | ﹤0.01% |
34,048
-2,304
| -6% | -$4.33K |
|
3187
Purple Innovation
PRPL
$33.2M
| $76.8K | ﹤0.01% |
4,649
+35
| +0.8% | +$612 |
|
3188
AN2 Therapeutics
ANTX
$177M
| $76.6K | ﹤0.01% |
+22,402
| New | +$46.2K |
|
3189
Playboy Inc
PLBY
$141M
| $76.1K | ﹤0.01% |
50,088
+6,062
| +14% | +$11.1K |
|
3190
Motorsport Games
MSGM
$18.2M
| $76.1K | ﹤0.01% |
18,555
+7,672
| +70% | +$29K |
|
3191
TriSalus Life Sciences
TLSI
$259M
| $76.1K | ﹤0.01% |
+19,014
| New | +$93.1K |
|
3192
BTCS Inc
BTCS
$49.3M
| $76K | ﹤0.01% |
54,707
-31,318
| -36% | -$63.9K |
|
|
IRD
3193
Opus Genetics
IRD
$254M
| $76K | ﹤0.01% |
16,704
-7,033
| -30% | -$24.3K |
|
|
JMG
3194
DELISTED
JM Group Ltd
JMG
| $75.7K | ﹤0.01% |
+11,458
| New | +$77.5K |
|
|
IMA
3195
ImageneBio Inc
IMA
$63.1M
| $75.6K | ﹤0.01% |
15,112
+2,935
| +24% | +$19K |
|
|
FGNX
3196
FG Nexus Inc
FGNX
$37.6M
| $75.5K | ﹤0.01% |
15,136
-15,421
| -50% | -$157K |
|
|
SRG
3197
Seritage Growth Properties
SRG
$130M
| $75.2K | ﹤0.01% |
26,756
-56
| -0.2% | -$175 |
|
|
AARD
3198
Aardvark Therapeutics
AARD
$138M
| $75.1K | ﹤0.01% |
19,915
-5,633
| -22% | -$58.4K |
|
3199
ProFrac Holding
ACDC
$771M
| $74.9K | ﹤0.01% |
+12,083
| New | +$64.7K |
|
3200
Cineverse
CNVS
$55M
| $74.6K | ﹤0.01% |
31,093
+1,967
| +7% | +$4.74K |
|
Similar funds
HW
AAM
RWM
SAM
FWI
PP
VH
TSW
XTX Topco's Q1 2026 Portfolio in Review
As of Q1 2026, XTX Topco held 4,587 positions worth $5.75B, up 51% from $3.81B the previous quarter. Its ten largest holdings account for 4% of the portfolio.
XTX Topco deployed $2.28B of net new capital in Q1 2026, opening 1,332 new positions and adding to 1,451 existing holdings. Its largest new stake was Duke Energy: 150,199 shares worth $19.7M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $24M trimmed.
- XTX Topco's largest Q1 2026 buy was Duke Energy: 150,199 shares worth $19.7M.
- XTX Topco added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $34.9M increase.
- XTX Topco's biggest Q1 2026 reduction was JPMorgan Chase, cutting an estimated $24M.
- XTX Topco fully exited Procter & Gamble in Q1 2026, selling an estimated $27.9M.
- XTX Topco's ten largest holdings make up 4% of its $5.75B portfolio in Q1 2026.
- XTX Topco opened 1,332 new positions and closed 814 in Q1 2026.
- XTX Topco's portfolio value rose 51% quarter-over-quarter to $5.75B.
Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.